 |
Recombinant human factor IX protein modified with three point mutations |
|---|---|
| Trade Name | |
| Orphan Indication | Hemophilia B |
| EU Market Approval | EU |
| EU Designation Date | 2017-06-20 00:00:00 |
| Sponsor | Voisin Consulting S.A.R.L. |
| |
Recombinant human factor IX protein modified with three point mutations |
|---|---|
| Trade Name | |
| Orphan Indication | Hemophilia B |
| EU Market Approval | EU |
| EU Designation Date | 2017-06-20 00:00:00 |
| Sponsor | Voisin Consulting S.A.R.L. |